openPR Logo
Press release

Toxoplasmosis Testing Market Valuation By 2021

05-06-2018 06:49 AM CET | Health & Medicine

Press release from: Persistence Market Research

The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and intestines of infected persons. In addition, it is transmitted by pregnant women to their developing fetuses through the placenta. The severity of toxoplasmosis depends upon the stage of pregnancy at which women acquires the infection. Infection results in premature birth or spontaneous abortion. Toxoplasmosis exhibits mild symptoms such as swollen lymph nodes and discomfort.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/4289

However, in individuals with HIV/AIDS, it results in severe, life threatening, and recurring symptoms. Toxoplasmosis can be serious or fatal in fetuses, newborns, and people with weakened immune systems. Serology, polymerase chain reaction, and immunoperoxidase stain are some of the tests used to diagnose toxoplasmosis. Serology is used to measure immunoglobulin G (IgG) in infected persons. Toxoplasmosis testing is a blood test used to check for the availability of antibodies for T. gondii. Hospitals, commercial or private laboratories, and physician offices are among the common users of toxoplasmosis testing.

Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and increasing demand for effective testing methods by diagnostics laboratories in these regions. However, Asia is expected to be the fastest growing market in the next five years, due to the region’s developing healthcare infrastructure and increasing government initiatives for better healthcare facilities. Moreover, a large patient population base is also driving the growth of the toxoplasmosis testing market in this region.

Rising technological advancements in infection control instruments, an increasing number of anti-infective drugs, and the development of food sterilization and disinfection methods are among the key factors driving the growth of the global toxoplasmosis testing market. In addition, a rising birth rate and improving healthcare infrastructure in developing countries such as India, China and Brazil are also fuelling the growth of the global toxoplasmosis testing market. However, the lack of awareness among people about parasitic infections and economic downturn and saturation, and the high cost of toxoplasmosis tests are restraining the growth of the global toxoplasmosis testing market. In addition, stringent and time-consuming regulatory policies also impede the market’s growth.

Request a Sample Brochure of the Report @ https://www.persistencemarketresearch.com/samples/4289

Employment of single-use technology products and the availability of low-cost tests for toxoplasmosis could open up opportunities for new players in the global toxoplasmosis testing market. In addition, increasing focus on emerging markets such as India and China could also open up an opportunity for the market players in the global Toxoplasmosis testing market. Moreover, safety and quality of toxoplasmosis testing could be a challenge for the growth of the global toxoplasmosis testing market. A growing number of mergers and acquisitions is a recent trend in the global toxoplasmosis testing market.

The major companies operating in this market are Abbott Laboratories, Affymetrix, Inc., Bio-Rad Laboratories, Inc., and Beckman Coulter, Inc. Other significant players are Biomerica, Inc., Cepheid, Inc., Biotest, and GenBio.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Toxoplasmosis Testing Market Valuation By 2021 here

News-ID: 1040505 • Views:

More Releases from Persistence Market Research

Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by 2032
Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by …
Overview of the Market The Pedestrian Entrance Control Systems (PECS) market is poised for substantial growth over the coming years, driven by the increasing demand for secure and efficient access management solutions in commercial, residential, and industrial sectors. These systems are critical for controlling pedestrian flow while ensuring safety and compliance with security protocols. The market is witnessing rapid adoption due to rising urbanization, advancements in biometric and smart access technologies,
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Overview of the Digital Signature Market The global digital signature market is poised for remarkable growth, estimated to increase from US$ 8.4 billion in 2025 to US$ 38.5 billion by 2032, reflecting a robust CAGR of 25.8% during the forecast period. This surge is driven by the escalating demand for secure and efficient digital transaction solutions across industries such as BFSI, healthcare, government, and IT. Organizations are increasingly embracing digital signatures
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 2032
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 20 …
Overview of the Market The global family/indoor entertainment centers market is experiencing remarkable growth, fueled by increasing consumer demand for recreational and leisure activities. Estimated at US$ 46.8 billion in 2025, the market is projected to nearly double, reaching US$ 102.8 billion by 2032, registering a robust CAGR of 11.9% during the forecast period. Families and young adults are increasingly seeking immersive and interactive entertainment experiences, driving the popularity of indoor
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Persistence Market Research
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Pe …
Overview of the Market The global 5G network equipment market is set to experience exponential growth, with its size projected to rise from US$ 26,370.5 million in 2025 to US$ 101,824.3 million by 2032, reflecting a robust CAGR of 21.3% during the forecast period. The increasing need for ultra-fast wireless communication, low latency, and high network efficiency is driving the demand for 5G network infrastructure worldwide. Mobile operators and enterprises are

All 5 Releases


More Releases for Toxoplasmosis

Toxoplasmosis Testing Market Insights, Forecast to 2031
"Toxoplasmosis Testing Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Toxoplasmosis Testing market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Toxoplasmosis Testing industry, providing stakeholders with a nuanced perspective on
Toxoplasmosis Treatment Drugs Market Key Trends And Forecast Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Toxoplasmosis Treatment Drugs Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The toxoplasmosis treatment drugs market size has grown strongly in recent
Global Toxoplasmosis Testing Market Research Report 2023-2029
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Global Toxoplasmosis Testing Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different
How Drugs For Toxoplasmosis Market Development is Changing Business Needs?
Drugs For Toxoplasmosis Market Study 2022-2027: Drugs For Toxoplasmosis Market (Newly published report) which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis, and focuses on various products and other market trends. The market research report on the global Drugs For Toxoplasmosis industry provides a comprehensive study of the various techniques and materials used in the production of Drugs For Toxoplasmosis market products. Starting from industry chain
Technological Apogee To Catalyze The Toxoplasmosis Testing Market
Toxoplasmosis is an infection induced by Toxoplasma gondii parasite. Mostly cats serve as reservoir for this parasite. Based on the 2017 disease data from European Centre for Disease Prevention and Control, countries including Poland, United Kingdom and Germany had comparatively higher number of reported cases of congenital toxoplasmosis in infants creating a need for preventive measures to be taken for toxoplasmosis testing. This disease is transmitted through improper cooked meat consumption,
Toxoplasmosis Diagnostic Testing Market: Evolving market trends and dynamics
Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii, one of the world’s most dreaded parasite. There are 3 major genotypes of Toxoplasma gondii, namely (type 1, type 2, and type 3). These genotypes differ in their pathogenicity and prevalence among people around the world. Toxoplasmosis may be caused by transmission of T.gondii parasite through open wounds, consumption of contaminated raw meat, mutton, pork, beef, or by transfusion